August 17, 2006

New Citations

A. Cord Blood Banking: Category XXI. iv, Processing, cryopreservation and infusion

Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. (Citation #3)

Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries. (Citation #4)

Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. (Citation #45)

Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood (Editorial). (Citation #6)

Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. (Citation #7)

Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34(+) cell quantification. (Citation #8)

The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. (Citation #9)

Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. (Citation #10)

B. Thalassemia: Category XII. ii. Thalassemia

Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia. (C. Umbilical Cord Blood Transplantation, Citation #1)

Unrelated BMT for Beta-thalassemia patients (B. Bone marrow and PBSC transplantation , Citation #3)

Severe infections in thalassemic patients (A. Clinical Aspects, Citation #10)

C. Reviews: Category I.

Why cord blood? (Citation #11)

Human umbilical cord blood biology, transplantation and plasticity. (Citation #13)

D. Ex-vivo expansion of HPC: Category XVIII

Direct evidence for ex vivo expansion of human hematopoietic stem cells. (Citation #6)

E. Adverse events in cord blood transplantation: Category XIV

High incidence of CMV reactivation in adult recipients of an unrelated CBT.
(i. Infections, Citation #9)